Ras-related protein Rab-11A
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 6–172 | Fragment:residues 7-173 Mutation:Q70L Non-standard monomer:Yes (specific site not provided by mmCIF) | Rab11 family-interacting protein 3 × 1 (O75154) MG MAGNESIUM ION × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K | Resolution 1.75 Å R-free 0.224 |
| 2 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain B; UniProt 6–172 | Fragment:residues 7-173 Mutation:Q70L Non-standard monomer:Yes (specific site not provided by mmCIF) | Rab11 family-interacting protein 3 × 1 (O75154) MG MAGNESIUM ION × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K | Resolution 1.75 Å R-free 0.224 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 2D7C | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1YZK GppNHp bound Rab11 GTPase Deposited 2005-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
8–175(168 aa)
|
Not recorded | MG MAGNESIUM ION × 1 GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;NaCl, Glycerol, MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 4K
|
Resolution 2.00 Å R-free 0.228 |
| 2GZD Crystal Structure of Rab11 in Complex with Rab11-FIP2 Deposited 2006-05-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–172(172 aa)
Fragment:G protein domain
Chain B
1–172(172 aa)
Fragment:G protein domain
|
Mutation:Q70L Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:Q70L Non-standard monomer:Yes (specific site not provided by mmCIF) | MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5;298 K;Ammonium phosphate buffer, between 0.1 and 0.5 M concentration, VAPOR DIFFUSION, temperature 298K
|
Resolution 2.44 Å R-free 0.279 |
| 2GZH Crystal Structure of Rab11 in Complex with Rab11-Family Interacting Protein 2 Deposited 2006-05-11 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–172(172 aa)
Fragment:G protein domain
|
Mutation:Q70L Non-standard monomer:Yes (specific site not provided by mmCIF) | PO4 PHOSPHATE ION × 2 MG MAGNESIUM ION × 4 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5;298 K;Ammonium phosphate buffer, approximately 0.3M concentration, pH 5, VAPOR DIFFUSION, temperature 298K
|
Resolution 2.47 Å R-free 0.254 |
| 2HV8 Crystal structure of GTP-bound Rab11 in complex with FIP3 Deposited 2006-07-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
5–174(170 aa)
Fragment:GTPase domain
|
Mutation:Q70L | MG MAGNESIUM ION × 2 SO4 SULFATE ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.86 Å R-free 0.237 |
| 2HV8 Crystal structure of GTP-bound Rab11 in complex with FIP3 Deposited 2006-07-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
5–174(170 aa)
Fragment:GTPase domain
Chain C
5–174(170 aa)
Fragment:GTPase domain
|
Mutation:Q70L Mutation:Q70L | MG MAGNESIUM ION × 2 SO4 SULFATE ION × 4 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 2ME METHOXYETHANE × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.86 Å R-free 0.237 |
| 4C4P Crystal Structure of Wild-Type Rab11 Complexed to FIP2 Deposited 2013-09-07 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–173(173 aa)
Fragment:RESIDUES 1-173
|
Not recorded | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.00 Å R-free 0.223 |
| 4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Mutation:YES | 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
|
Resolution 2.94 Å R-free 0.259 |
| 4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
1–216(216 aa)
|
Mutation:YES | 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
|
Resolution 2.94 Å R-free 0.259 |
| 4D0L Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS Deposited 2014-04-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
1–216(216 aa)
|
Mutation:YES | 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
|
Resolution 2.94 Å R-free 0.259 |
| 4D0M Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3 Deposited 2014-04-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain B
1–216(216 aa)
Chain D
1–216(216 aa)
Chain P
1–216(216 aa)
Chain T
1–216(216 aa)
|
Mutation:YES Mutation:YES Mutation:YES Mutation:YES | 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
16% PEG 6K, 0.01 M NA CITRATE
|
Resolution 6.00 Å R-free 0.359 |
| 4D0M Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3 Deposited 2014-04-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain H
1–216(216 aa)
Chain J
1–216(216 aa)
Chain N
1–216(216 aa)
Chain R
1–216(216 aa)
|
Mutation:YES Mutation:YES Mutation:YES Mutation:YES | 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
16% PEG 6K, 0.01 M NA CITRATE
|
Resolution 6.00 Å R-free 0.359 |
| 4D0M Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3 Deposited 2014-04-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric |
Chain X
1–216(216 aa)
Chain Z
1–216(216 aa)
Chain d
1–216(216 aa)
Chain h
1–216(216 aa)
|
Mutation:YES Mutation:YES Mutation:YES Mutation:YES | 093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4 MG MAGNESIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
16% PEG 6K, 0.01 M NA CITRATE
|
Resolution 6.00 Å R-free 0.359 |
| 4LWZ Crystal structure of Myo5b globular tail domain in complex with inactive Rab11a Deposited 2013-07-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;17% peg, 100 mM NaCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.55 Å R-free 0.295 |
| 4LWZ Crystal structure of Myo5b globular tail domain in complex with inactive Rab11a Deposited 2013-07-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;17% peg, 100 mM NaCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.55 Å R-free 0.295 |
| 4LX0 Crystal structure of Myo5b globular tail domain in complex with active Rab11a Deposited 2013-07-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded | MG MAGNESIUM ION × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;10 % peg, 90 mM NaF, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.19 Å R-free 0.218 |
| 4LX0 Crystal structure of Myo5b globular tail domain in complex with active Rab11a Deposited 2013-07-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded | MG MAGNESIUM ION × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;10 % peg, 90 mM NaF, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.19 Å R-free 0.218 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain D
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain G
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain J
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain M
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 6 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 7 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain S
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ3 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 8 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain V
4–186(183 aa)
Fragment:GTPASE DOMAIN
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 PG4 TETRAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;50MM MES PH 5.6, 0.2M AMMONIUM SULFATE AND 12% PEG 8000
|
Resolution 3.00 Å R-free 0.250 |
| 4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
Chain G
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
|
Mutation:YES Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
|
Resolution 4.20 Å R-free 0.266 |
| 4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
Chain J
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
|
Mutation:YES Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
|
Resolution 4.20 Å R-free 0.266 |
| 4UJ4 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain A
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
Chain J
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
|
Mutation:YES Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 MG MAGNESIUM ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
|
Resolution 4.20 Å R-free 0.266 |
| 4UJ5 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
6–186(181 aa)
Fragment:GTPASE DOMAIN, RESIDUES 6-186
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;0.1M HEPES PH 7.0, 0.2M LITHIUM SULFATE AND 24% PEG 3350
|
Resolution 2.60 Å R-free 0.272 |
| 4UJ5 Crystal structure of human Rab11-Rabin8-FIP3 Deposited 2015-04-08 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
6–186(181 aa)
Fragment:GTPASE DOMAIN, RESIDUES 6-186
|
Mutation:YES | GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;0.1M HEPES PH 7.0, 0.2M LITHIUM SULFATE AND 24% PEG 3350
|
Resolution 2.60 Å R-free 0.272 |
| 5C46 Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta in complex with GTP gamma S loaded Rab11 Deposited 2015-06-17 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
1–216(216 aa)
|
Mutation:Q70L | SO4 SULFATE ION × 2 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;290 K;PEG-4000, sodium citrate, ammonium sulfate, glycerol
|
Resolution 2.65 Å R-free 0.246 |
| 5C4G Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with the inhibitor BQR695 in complex with GDP loaded Rab11 Deposited 2015-06-18 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Mutation:Q70L | MG MAGNESIUM ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 SO4 SULFATE ION × 2 BQR N~2~-[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]-N-methylglycinamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;290 K;PEG-4000, sodium citrate, ammonium sulfate, glycerol
|
Resolution 3.20 Å R-free 0.287 |
| 5EUQ Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with a potent and selective inhibitor in complex with GDP loaded Rab11 Deposited 2015-11-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 SO4 SULFATE ION × 2 5S8 ~{N}-[5-[3-[[(4-hydroxyphenyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-4-methoxy-phenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;290 K;PEG-4000, sodium citrate, ammonium sulfate, glycerol
|
Resolution 3.20 Å R-free 0.266 |
| 5EZ5 Crystal structure of active Rab11A (S20V) in complex with GTP Deposited 2015-11-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
8–175(168 aa)
Fragment:UNP residues 8-175
Chain B
8–175(168 aa)
Fragment:UNP residues 8-175
|
Mutation:S20V Mutation:S20V | MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Sodium chloride, Tris, Magnessium chloride
|
Resolution 2.40 Å R-free 0.304 |
| 5EZ5 Crystal structure of active Rab11A (S20V) in complex with GTP Deposited 2015-11-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
8–175(168 aa)
Fragment:UNP residues 8-175
Chain B
8–175(168 aa)
Fragment:UNP residues 8-175
|
Mutation:S20V Mutation:S20V | MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Sodium chloride, Tris, Magnessium chloride
|
Resolution 2.40 Å R-free 0.304 |
| 5FBL PI4KB in complex with Rab11 and the MI356 Inhibitor Deposited 2015-12-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Not recorded | 5W9 ~{N}-[2-[[6-chloranyl-3-(4-methoxy-3-morpholin-4-ylsulfonyl-phenyl)-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;1M Lithium chloride, 0.1M Citric acid pH=5, 10% (w/v) PEG 6000
|
Resolution 3.37 Å R-free 0.269 |
| 5FBQ PI4KB in complex with Rab11 and the MI358 Inhibitor Deposited 2015-12-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Not recorded | 5W6 ~{N}-[2-[[6-chloranyl-3-[3-[4-(hydroxymethyl)piperidin-1-yl]sulfonyl-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.2M magnesium chloride, 0.1M Tris PH=7, 10% (w/v) PEG 8000
|
Resolution 3.79 Å R-free 0.302 |
| 5FBR PI4KB in complex with Rab11 and the MI359 Inhibitor Deposited 2015-12-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Not recorded | 5W7 ~{N}-[2-[[3-[3-[(4-azanylcyclohexyl)sulfamoyl]-4-methoxy-phenyl]-6-chloranyl-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.15M amonium sulfate, 0.1M MES pH=6, 15% PEG 4000
|
Resolution 3.28 Å R-free 0.264 |
| 5FBV PI4KB in complex with Rab11 and the MI364 Inhibitor Deposited 2015-12-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Not recorded | 5W3 ~{N}-[2-[[6-chloranyl-3-[3-(2-hydroxyethylsulfamoyl)-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethy l]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.15M amonium sulfate, 0.1M MEW pH=6, 15% PEG 4000
|
Resolution 3.29 Å R-free 0.281 |
| 5FBW PI4KB in complex with Rab11 and the MI369 Inhibitor Deposited 2015-12-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Not recorded | 5W8 ~{N}-[2-[[6-chloranyl-3-[4-methoxy-3-[[(2~{R})-1-oxidanylbutan-2-yl]sulfamoyl]phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1 GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.2M ammonium sulfate, 0.1M MES pH=6.5, 20% (w/v) PEG 8000
|
Resolution 3.49 Å R-free 0.283 |
| 5JCZ Rab11 bound to MyoVa-GTD Deposited 2016-04-15 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–177(177 aa)
|
Not recorded | MG MAGNESIUM ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 EDO 1,2-ETHANEDIOL × 5 ACT ACETATE ION × 1 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
|
Resolution 2.06 Å R-free 0.208 |
| 5JCZ Rab11 bound to MyoVa-GTD Deposited 2016-04-15 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
1–177(177 aa)
|
Not recorded | MG MAGNESIUM ION × 2 GDP GUANOSINE-5'-DIPHOSPHATE × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 EDO 1,2-ETHANEDIOL × 6 ACT ACETATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
|
Resolution 2.06 Å R-free 0.208 |
| 5JCZ Rab11 bound to MyoVa-GTD Deposited 2016-04-15 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain I
1–177(177 aa)
|
Not recorded | MG MAGNESIUM ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 BEF BERYLLIUM TRIFLUORIDE ION × 1 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
|
Resolution 2.06 Å R-free 0.208 |
| 6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–216(216 aa)
|
Mutation:Q70L | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å R-free 0.278 |
| 6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
1–216(216 aa)
|
Mutation:Q70L | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å R-free 0.278 |
| 6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain G
1–216(216 aa)
|
Mutation:Q70L | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å R-free 0.278 |
| 6DJL Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A Deposited 2018-05-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
1–216(216 aa)
|
Mutation:Q70L | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å R-free 0.278 |
| 6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain E
1–173(173 aa)
|
Not recorded | PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å R-free 0.259 |
| 6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
1–173(173 aa)
|
Not recorded | PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å R-free 0.259 |
| 6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain G
1–173(173 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å R-free 0.259 |
| 6IXV Crystal structure of SH3BP5-Rab11a Deposited 2018-12-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
1–173(173 aa)
|
Not recorded | PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å R-free 0.259 |
| 6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
9–173(165 aa)
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å R-free 0.261 |
| 6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
9–173(165 aa)
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å R-free 0.261 |
| 6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
9–173(165 aa)
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å R-free 0.261 |
| 6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
7–173(167 aa)
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å R-free 0.261 |
| 6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain E
9–173(165 aa)
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å R-free 0.261 |
| 6IY1 Structure of human Ras-related protein Rab11 Deposited 2018-12-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 6 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain F
6–173(168 aa)
|
Not recorded | GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å R-free 0.261 |
| 8VOF GI targeted CpPI4K inhibitor Deposited 2024-01-15 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
1–216(216 aa)
|
Mutation:Q70L | A1ADE methyl 2-chloro-5-(methyl{(8R)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carbonyl}amino)benzoate × 1 SO4 SULFATE ION × 1 GDP GUANOSINE-5'-DIPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;294 K;0.5M ammonium sulfate, 0.088M sodium citrate, 0.875M lithium sulfate, 2.4% glycerol, 2.5% ethylene glycol, 50mM HEPES pH 6.8
|
Resolution 3.00 Å R-free 0.270 |
26 other PDB entries and 57 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | RB11A_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–167; UniProt 6–172 Author chain B; PDBConstruct 1–167; UniProt 6–172 |